According to Zacks, “Essilor International researches, develops, manufactures and markets around the world a wide range of lenses to improve and protect eyesight. It creates lenses for various types of visual disorders such as myopia, hypermetropia, presbyopia and stigmatism. The group’s know-how also covers the manufacture and sale of optical instruments mainly machines used to edge finished lenses and diagnose visual disorders. The Company sells its products through various flagship brands such as Varilux, Crizal, Essilor, Definity and Xperio. Essilor International is headquartered in Charenton-le-Pont, France. “
Other equities research analysts have also recently issued reports about the company. Credit Suisse Group AG started coverage on Essilor International SA in a report on Friday, March 17th. They issued an outperform rating for the company. Barclays PLC started coverage on Essilor International SA in a report on Thursday, March 9th. They issued an overweight rating for the company.
Shares of Essilor International SA (NASDAQ:ESLOY) opened at 61.30 on Tuesday. The company has a 50-day moving average price of $58.52 and a 200 day moving average price of $58.26. Essilor International SA has a 12-month low of $50.35 and a 12-month high of $67.99. The company has a market capitalization of $26.41 billion and a P/E ratio of 30.77.
WARNING: “Essilor International SA (ESLOY) Rating Lowered to Sell at Zacks Investment Research” was posted by Mideast Time and is owned by of Mideast Time. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.mideasttime.com/essilor-international-sa-esloy-rating-lowered-to-sell-at-zacks-investment-research/1588712.html.
About Essilor International SA
Essilor International SA, formerly Essilor International Compagnie Generale D’Optique SA, is an ophthalmic optics company. The Company designs, manufactures and markets a range of lenses to improve and protect eyesight. It also develops and markets equipment for prescription laboratories, and instruments and services for eye care professionals.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Essilor International SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Essilor International SA and related companies with MarketBeat.com's FREE daily email newsletter.